Cargando…

Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats

Syringic acid (SA) is a phenolic acid and have been investigated for diverse pharmacological activities, but the safety and/or mechanism of toxicity is still lacking in the literature. Subacute toxicity studies will add value to its pharmacological profile and support its exploration as a future med...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirza, Anwarbaig C., Panchal, Shital S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706588/
https://www.ncbi.nlm.nih.gov/pubmed/31463381
http://dx.doi.org/10.1016/j.heliyon.2019.e02129
_version_ 1783445717662040064
author Mirza, Anwarbaig C.
Panchal, Shital S.
author_facet Mirza, Anwarbaig C.
Panchal, Shital S.
author_sort Mirza, Anwarbaig C.
collection PubMed
description Syringic acid (SA) is a phenolic acid and have been investigated for diverse pharmacological activities, but the safety and/or mechanism of toxicity is still lacking in the literature. Subacute toxicity studies will add value to its pharmacological profile and support its exploration as a future medicine. According to OECD TG 407 (OECD, 2008), rats were divided into 3 groups (n = 12). The dose of SA was decided by limit test. Treatment and satellite groups received SA (1000 mg/kg/day, p.o for 14 days), whereas an equal volume of vehicle was given to control groups. In order to access reversibility, satellite groups were kept for another 14 days post-treatment. The toxic signs, mortality and body weight changes were recorded. On day 15 and 29 the rats were anesthetized to collect blood for estimation of hematological and biochemical parameters and then sacrificed to collect internal body organ for weighing and histopathological studies. SA has no major adverse effect on the body weight, food intake, erythropoiesis, leucopoiesis and on internal body organs which was confirmed by evaluating various biochemical and hematological parameters, relative body organ weight and histopathological studies. Therefore, SA could be considered safe over limited period of time and this study may help researchers in establishing the doses for the longer-term subchronic studies. Further, subchronic and chronic toxicity studies are required to evaluate safety on long term use.
format Online
Article
Text
id pubmed-6706588
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67065882019-08-28 Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats Mirza, Anwarbaig C. Panchal, Shital S. Heliyon Article Syringic acid (SA) is a phenolic acid and have been investigated for diverse pharmacological activities, but the safety and/or mechanism of toxicity is still lacking in the literature. Subacute toxicity studies will add value to its pharmacological profile and support its exploration as a future medicine. According to OECD TG 407 (OECD, 2008), rats were divided into 3 groups (n = 12). The dose of SA was decided by limit test. Treatment and satellite groups received SA (1000 mg/kg/day, p.o for 14 days), whereas an equal volume of vehicle was given to control groups. In order to access reversibility, satellite groups were kept for another 14 days post-treatment. The toxic signs, mortality and body weight changes were recorded. On day 15 and 29 the rats were anesthetized to collect blood for estimation of hematological and biochemical parameters and then sacrificed to collect internal body organ for weighing and histopathological studies. SA has no major adverse effect on the body weight, food intake, erythropoiesis, leucopoiesis and on internal body organs which was confirmed by evaluating various biochemical and hematological parameters, relative body organ weight and histopathological studies. Therefore, SA could be considered safe over limited period of time and this study may help researchers in establishing the doses for the longer-term subchronic studies. Further, subchronic and chronic toxicity studies are required to evaluate safety on long term use. Elsevier 2019-08-14 /pmc/articles/PMC6706588/ /pubmed/31463381 http://dx.doi.org/10.1016/j.heliyon.2019.e02129 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Mirza, Anwarbaig C.
Panchal, Shital S.
Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats
title Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats
title_full Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats
title_fullStr Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats
title_full_unstemmed Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats
title_short Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats
title_sort safety evaluation of syringic acid: subacute oral toxicity studies in wistar rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706588/
https://www.ncbi.nlm.nih.gov/pubmed/31463381
http://dx.doi.org/10.1016/j.heliyon.2019.e02129
work_keys_str_mv AT mirzaanwarbaigc safetyevaluationofsyringicacidsubacuteoraltoxicitystudiesinwistarrats
AT panchalshitals safetyevaluationofsyringicacidsubacuteoraltoxicitystudiesinwistarrats